The future trends in pharma supply chain and logistics, emphasising digitalisation, risk management, cold chain, and data security for resilient healthcare.
Building a resilient perinatal drug supply chain through diversification, technology, policy, and digital tools is essential for maternal and neonatal health.
The biosimulation market size, market growth, regional insights, and technological advances shaping the future of drug discovery and personalised medicine.
The emerging small-molecule drugs for ultra-rare diseases are revolutionizing treatment with accessible, and innovative therapies driven by medical advancements
FDA approves Ekterly, an on-demand oral therapy for treating hereditary angioedema attacks, offering faster symptom relief to patients aged 12 years and older
